Literature DB >> 22674620

Purinergic receptors in microglia: functional modal shifts of microglia mediated by P2 and P1 receptors.

Schuichi Koizumi1, Keiko Ohsawa, Kazuhide Inoue, Shinichi Kohsaka.   

Abstract

Microglia are sensitive to environmental changes and are immediately transformed into several phenotypes. For such dynamic "modal shifts", purinergic receptors have central roles. When microglia sense ATP/ADP leaked from injured cells by P2Y(12) receptors, they are transformed into a moving phenotype, showing process extension and migration toward the injured sites. Microglia upregulate adenosine A(2A) receptors, by which they retract the processes showing an amoeboid-shaped, activated phenotype. Microglia also upregulate P2Y(6) receptors, and if they meet UDP leaked from dead cells, microglia start to engulf and eat the dead cells as a phagocytic phenotype. The P2Y(12) receptor-mediated responses are modulated by other P2 or P1 receptors. In contrast, the P2Y(6) receptor-mediated responses were not influenced by P2Y(12) receptors and vice versa. Microglia appear to use purinergic signals either cooperatively or distinctively to cause their modal shifts.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22674620     DOI: 10.1002/glia.22358

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  63 in total

Review 1.  Central nervous system myeloid cells as drug targets: current status and translational challenges.

Authors:  Knut Biber; Thomas Möller; Erik Boddeke; Marco Prinz
Journal:  Nat Rev Drug Discov       Date:  2015-12-04       Impact factor: 84.694

Review 2.  Supportive or detrimental roles of P2Y receptors in brain pathology?--The two faces of P2Y receptors in stroke and neurodegeneration detected in neural cell and in animal model studies.

Authors:  Daniel Förster; Georg Reiser
Journal:  Purinergic Signal       Date:  2015-09-25       Impact factor: 3.765

3.  Adenosine A2A receptor antagonism reverses inflammation-induced impairment of microglial process extension in a model of Parkinson's disease.

Authors:  Stefka Gyoneva; Lauren Shapiro; Carlos Lazo; Ethel Garnier-Amblard; Yoland Smith; Gary W Miller; Stephen F Traynelis
Journal:  Neurobiol Dis       Date:  2014-03-13       Impact factor: 5.996

Review 4.  Purinergic receptors as potential therapeutic targets in Alzheimer's disease.

Authors:  Lucas T Woods; Deepa Ajit; Jean M Camden; Laurie Erb; Gary A Weisman
Journal:  Neuropharmacology       Date:  2015-10-28       Impact factor: 5.250

5.  Analysis of microglial migration by a micropipette assay.

Authors:  Hang-jun Wu; Yi-jun Liu; Hui-quan Li; Cong Chen; Ying Dou; Hui-fang Lou; Margaret S Ho; Xiao-ming Li; Zhihua Gao; Shumin Duan
Journal:  Nat Protoc       Date:  2014-01-30       Impact factor: 13.491

Review 6.  The immune system as a novel regulator of sex differences in brain and behavioral development.

Authors:  Lars H Nelson; Kathryn M Lenz
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

Review 7.  Purinergic signaling in oligodendrocyte development and function.

Authors:  Taylor G Welsh; Sarah Kucenas
Journal:  J Neurochem       Date:  2018-03-25       Impact factor: 5.372

Review 8.  NLRP3 inflammasomes are involved in the progression of postoperative cognitive dysfunction: from mechanism to treatment.

Authors:  Shuai Zhao; Fan Chen; Dunwei Wang; Wei Han; Yuan Zhang; Qiliang Yin
Journal:  Neurosurg Rev       Date:  2020-09-12       Impact factor: 3.042

9.  Protein Interacting C-Kinase 1 Modulates Surface Expression of P2Y6 Purinoreceptor, Actin Polymerization and Phagocytosis in Microglia.

Authors:  Jia Zhu; Zhen Wang; Nan Zhang; Jiao Ma; Shui-Lin Xu; Yin Wang; Ying Shen; Yun-Hong Li
Journal:  Neurochem Res       Date:  2015-11-13       Impact factor: 3.996

10.  Induction of a Senescence-Like Phenotype in Cultured Human Fetal Microglia During HIV-1 Infection.

Authors:  Natalie C Chen; Andrea T Partridge; Ferit Tuzer; Justin Cohen; Timothy Nacarelli; Sonia Navas-Martín; Christian Sell; Claudio Torres; Julio Martín-García
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-08-10       Impact factor: 6.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.